Companies / BOC Sciences / Golimumab
BOC Sciences

Golimumab | BOC Sciences

Golimumab is a monoclonal antibody used in the treatment of autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Golimumab targets and inhibits tumor necrosis factor alpha (TNF-_), a cytokine involved in the inflammatory pathway that contributes to autoimmune diseases. By blocking TNF-_, golimumab helps to reduce inflammation and alleviate symptoms associated with these conditions.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.